Variant report

Variant	esv3440316
Chromosome Location	chr21:40031607-40034455
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr21:40033470-40033725	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr21:40032298-40033018	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr21:40033087-40033424	H1-hESC	embryonic stem cell:	n/a	n/a
4	CEBPB	chr21:40033873-40034214	IMR90	lung:	n/a	n/a
5	CEBPB	chr21:40033114-40033338	HepG2	liver:	n/a	n/a
6	CEBPB	chr21:40033139-40033386	IMR90	lung:	n/a	n/a
7	CHD2	chr21:40033401-40033511	H1-hESC	embryonic stem cell:	n/a	n/a
8	CTBP2	chr21:40032103-40033755	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr21:40033440-40033590	GM12871	blood:	n/a	n/a
10	CTCF	chr21:40032407-40032501	Fibrobl	skin:	n/a	n/a
11	E2F6	chr21:40032301-40033673	H1-hESC	embryonic stem cell:	n/a	chr21:40032692-40032701 chr21:40032506-40032515
12	E2F6	chr21:40032297-40033764	H1-hESC	embryonic stem cell:	n/a	chr21:40032692-40032701 chr21:40032506-40032515
13	EGR1	chr21:40032555-40032878	K562	blood:	n/a	chr21:40032687-40032700 chr21:40032692-40032702
14	EGR1	chr21:40032426-40033060	ECC-1	luminal epithelium:	n/a	chr21:40032687-40032700 chr21:40032692-40032702
15	EGR1	chr21:40032477-40033111	ECC-1	luminal epithelium:	n/a	chr21:40032687-40032700 chr21:40032692-40032702
16	EGR1	chr21:40032494-40033110	H1-hESC	embryonic stem cell:	n/a	chr21:40032687-40032700 chr21:40032692-40032702
17	EGR1	chr21:40032519-40033160	MCF-7	breast:	n/a	chr21:40032687-40032700 chr21:40032692-40032702
18	ELK1	chr21:40033918-40033922	GM12878	blood:	n/a	n/a
19	FOXA1	chr21:40033824-40034147	HepG2	liver:	n/a	n/a
20	HA-E2F1	chr21:40032583-40033554	MCF-7	breast:	n/a	chr21:40032692-40032701
21	HDAC2	chr21:40032388-40033119	H1-hESC	embryonic stem cell:	n/a	n/a
22	HDAC2	chr21:40032516-40033158	MCF-7	breast:	n/a	n/a
23	HDAC2	chr21:40032631-40032920	H1-hESC	embryonic stem cell:	n/a	n/a
24	MAX	chr21:40033136-40033674	A549	lung:	n/a	chr21:40033420-40033427
25	MAX	chr21:40032255-40033077	ECC-1	luminal epithelium:	n/a	chr21:40032425-40032434
26	MAX	chr21:40032192-40033108	ECC-1	luminal epithelium:	n/a	chr21:40032227-40032237 chr21:40032425-40032434
27	MAX	chr21:40033362-40033562	A549	lung:	n/a	chr21:40033420-40033427
28	MAX	chr21:40033154-40033521	ECC-1	luminal epithelium:	n/a	chr21:40033420-40033427
29	MAX	chr21:40032486-40033693	MCF-7	breast:	n/a	chr21:40033420-40033427
30	MAX	chr21:40032251-40033696	H1-hESC	embryonic stem cell:	n/a	chr21:40033420-40033427 chr21:40032425-40032434
31	MAX	chr21:40032780-40033689	H1-hESC	embryonic stem cell:	n/a	chr21:40033420-40033427
32	MAX	chr21:40033230-40033601	A549	lung:	n/a	chr21:40033420-40033427
33	MAX	chr21:40033144-40033556	H1-hESC	embryonic stem cell:	n/a	chr21:40033420-40033427
34	MXI1	chr21:40033279-40033399	H1-hESC	embryonic stem cell:	n/a	n/a
35	MXI1	chr21:40032419-40032530	H1-hESC	embryonic stem cell:	n/a	n/a
36	MYC	chr21:40033379-40033413	MCF-7	breast:	n/a	n/a
37	MYC	chr21:40032418-40032596	MCF-7	breast:	n/a	chr21:40032425-40032434
38	MYC	chr21:40033249-40033296	H1-hESC	embryonic stem cell:	n/a	n/a
39	MYC	chr21:40032663-40032889	MCF-7	breast:	n/a	n/a
40	MYC	chr21:40033329-40033487	MCF-7	breast:	n/a	chr21:40033420-40033427
41	POLR2A	chr21:40032786-40033097	MCF-7	breast:	n/a	n/a
42	POLR2A	chr21:40033052-40033677	H1-neurons	neurons:	n/a	n/a
43	POLR2A	chr21:40033417-40033419	MCF-7	breast:	n/a	n/a
44	POLR2A	chr21:40032604-40033159	HL-60	blood:	n/a	n/a
45	POLR2A	chr21:40032760-40033178	MCF-7	breast:	n/a	n/a
46	POLR2A	chr21:40032720-40033131	ProgFib	skin:	n/a	n/a
47	POLR2A	chr21:40032753-40032756	MCF-7	breast:	n/a	n/a
48	POLR2A	chr21:40032384-40032847	H1-neurons	neurons:	n/a	n/a
49	POLR2A	chr21:40032902-40033619	H1-neurons	neurons:	n/a	n/a
50	PRDM1	chr21:40033833-40034187	Hela-S3	cervix:	n/a	chr21:40034015-40034030 chr21:40034016-40034030 chr21:40034017-40034026

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr21:40033154-40033204	GM19239	blood:	n/a
2	chr21:40033154-40033204	GM19239	blood:	n/a
3	chr21:40033892-40033942	ECC-1	luminal epithelium:	n/a
4	chr21:40033634-40033684	BE2_C	brain:	n/a
5	chr21:40033163-40033213	MCF-7	breast:	n/a
6	chr21:40033154-40033204	HIPEpiC	eye:	n/a
7	chr21:40032331-40032381	Hela-S3	cervix:	n/a
8	chr21:40033892-40033942	HEK293	kidney:	embryo
9	chr21:40033163-40033213	U87	brain:	n/a
10	chr21:40032331-40032381	HIPEpiC	eye:	n/a
11	chr21:40033892-40033942	AG04450	lung:	fetal
12	chr21:40033634-40033684	GM12892	blood:	n/a
13	chr21:40033634-40033684	HepG2	liver:	n/a
14	chr21:40033634-40033684	NHBE	bronchial:	n/a
15	chr21:40033154-40033204	HL-60	blood:	n/a
16	chr21:40033892-40033942	HUVEC	blood vessel:	n/a
17	chr21:40033154-40033204	SK-N-SH	brain:	n/a
18	chr21:40033154-40033204	AG09319	gingival:	n/a
19	chr21:40033163-40033213	NH-A	brain:	n/a
20	chr21:40033154-40033204	Jurkat	blood:	n/a
21	chr21:40033634-40033684	AG09309	skin:	n/a
22	chr21:40033634-40033684	ovcar-3	ovarian:	n/a
23	chr21:40032331-40032381	SK-N-SH	brain:	n/a
24	chr21:40032331-40032381	NH-A	brain:	n/a
25	chr21:40033634-40033684	ECC-1	luminal epithelium:	n/a
26	chr21:40032331-40032381	HRPEpiC	eye:	n/a
27	chr21:40033154-40033204	SK-N-MC	brain:	n/a
28	chr21:40033634-40033684	U87	brain:	n/a
29	chr21:40033892-40033942	U87	brain:	n/a
30	chr21:40033634-40033684	SK-N-SH_RA	brain:	n/a
31	chr21:40033892-40033942	NT2-D1	testis:	n/a
32	chr21:40032331-40032381	HCT-116	colon:	n/a
33	chr21:40033163-40033213	HepG2	liver:	n/a
34	chr21:40033163-40033213	MCF10A-Er-Src	breast:	n/a
35	chr21:40032331-40032381	HEEpiC	esophagus:	n/a
36	chr21:40032331-40032381	MCF-7	breast:	n/a
37	chr21:40033634-40033684	SK-N-MC	brain:	n/a
38	chr21:40033892-40033942	HCM	heart:	n/a
39	chr21:40033154-40033204	HNPCEpiC	eye:	n/a
40	chr21:40033163-40033213	Caco-2	colon:	n/a
41	chr21:40033634-40033684	RPTEC	kidney:	n/a
42	chr21:40033163-40033213	SAEC	small airway:	n/a
43	chr21:40033163-40033213	GM19239	blood:	n/a
44	chr21:40033634-40033684	NH-A	brain:	n/a
45	chr21:40033892-40033942	AoSMC	blood vessel:	n/a
46	chr21:40033163-40033213	HRCEpiC	kidney:	n/a
47	chr21:40033892-40033942	HepG2	liver:	n/a
48	chr21:40032331-40032381	AG09309	skin:	n/a
49	chr21:40033634-40033684	PANC-1	pancreas:	n/a
50	chr21:40033163-40033213	PANC-1	pancreas:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr21:40032723..40034705-chr21:40552796..40555245,2	MCF-7	breast:
2	chr21:40030626..40032570-chr21:40036833..40038338,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DSCR4-16	chr21:40033582-40033618	NONHSAT082106

Variant related genes	Relation type
ERG	TF binding region
ERG	CpG island
ENSG00000183527	chromatin interactions

Extended variants
information (count: 95 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:95 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs148205077	chr21:40031647-40031648	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs540519659	chr21:40031737-40031738	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs559935939	chr21:40031845-40031846	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs528879895	chr21:40031847-40031848	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs75897329	chr21:40031896-40031897	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs76590500	chr21:40031901-40031902	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs78389852	chr21:40031902-40031903	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs9647180	chr21:40031924-40031925	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs72394651	chr21:40031967-40031968	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs376955072	chr21:40031968-40031969	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs571492163	chr21:40032006-40032007	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs115101815	chr21:40032009-40032010	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs554039131	chr21:40032011-40032012	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs567816289	chr21:40032019-40032020	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs543997898	chr21:40032040-40032041	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs73905456	chr21:40032061-40032062	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs556248079	chr21:40032109-40032110	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs576499647	chr21:40032120-40032121	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs539111488	chr21:40032125-40032126	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs61085980	chr21:40032140-40032141	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs190768716	chr21:40032192-40032193	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs28718905	chr21:40032244-40032245	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs574728935	chr21:40032245-40032246	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs76967855	chr21:40032289-40032290	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs372813768	chr21:40032298-40032299	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs375707695	chr21:40032299-40032300	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs573813759	chr21:40032396-40032397	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs115186677	chr21:40032436-40032437	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs539671509	chr21:40032450-40032451	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs562316817	chr21:40032497-40032498	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs531334031	chr21:40032519-40032520	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs551051628	chr21:40032549-40032550	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs183087256	chr21:40032556-40032557	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs577878742	chr21:40032562-40032563	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs565184904	chr21:40032585-40032586	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs527880575	chr21:40032598-40032599	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs8132069	chr21:40032611-40032612	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs567962539	chr21:40032651-40032652	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs536515600	chr21:40032654-40032655	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs529092461	chr21:40032747-40032748	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs550174596	chr21:40032779-40032780	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs563917288	chr21:40032792-40032793	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs539178622	chr21:40032805-40032806	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs372498914	chr21:40032810-40032811	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs559093329	chr21:40032936-40032937	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs572527018	chr21:40032937-40032938	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs533988897	chr21:40032966-40032967	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs9975531	chr21:40033035-40033036	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs573903348	chr21:40033061-40033062	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs542535813	chr21:40033072-40033073	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	21364760	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Acute myeloid leukemia	17237825	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Down syndrome	20877625	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Prostate cancer	21147910	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Prostate cancer	17245344	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Prostate cancer	20562851	CNVD

Chromatin state (count:335 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:40028800-40034400	Active TSS	Breast Myoepithelial Primary Cells	Breast
2	chr21:40029800-40034600	Active TSS	Aorta	Aorta
3	chr21:40031200-40031800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
4	chr21:40031200-40034400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr21:40031400-40033800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
6	chr21:40031600-40031800	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
7	chr21:40031600-40031800	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
8	chr21:40031600-40032000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
9	chr21:40031600-40032000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
10	chr21:40031800-40032000	Bivalent Enhancer	Primary hematopoietic stem cells	blood
11	chr21:40031800-40032000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
12	chr21:40031800-40032000	Bivalent Enhancer	Thymus	Thymus
13	chr21:40031800-40032200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
14	chr21:40031800-40032200	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
15	chr21:40031800-40032400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr21:40031800-40033000	Bivalent Enhancer	Primary B cells from peripheral blood	blood
17	chr21:40031800-40033200	Bivalent/Poised TSS	Osteobl	bone
18	chr21:40031800-40033600	Flanking Bivalent TSS/Enh	Primary neutrophils fromperipheralblood	blood
19	chr21:40031800-40034000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
20	chr21:40031800-40034000	Bivalent/Poised TSS	Primary T cells from cord blood	blood
21	chr21:40031800-40034000	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
22	chr21:40031800-40034200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
23	chr21:40032000-40032200	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
24	chr21:40032000-40032200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
25	chr21:40032000-40032200	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
26	chr21:40032000-40032200	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr21:40032000-40032200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
28	chr21:40032000-40032200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
29	chr21:40032000-40032200	Enhancers	Esophagus	oesophagus
30	chr21:40032000-40032200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
31	chr21:40032000-40032200	Bivalent Enhancer	Fetal Stomach	stomach
32	chr21:40032000-40032200	Enhancers	Lung	lung
33	chr21:40032000-40032200	Bivalent Enhancer	Right Ventricle	heart
34	chr21:40032000-40032400	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr21:40032000-40032400	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
36	chr21:40032000-40032400	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
37	chr21:40032000-40032400	Bivalent Enhancer	Fetal Muscle Leg	muscle
38	chr21:40032000-40032600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
39	chr21:40032000-40032600	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
40	chr21:40032000-40032800	Bivalent/Poised TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
41	chr21:40032000-40032800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
42	chr21:40032000-40032800	Bivalent Enhancer	Placenta	Placenta
43	chr21:40032000-40032800	Bivalent Enhancer	Fetal Thymus	thymus
44	chr21:40032000-40033200	Bivalent/Poised TSS	Skeletal Muscle Female	skeletal muscle
45	chr21:40032000-40033200	Flanking Bivalent TSS/Enh	Thymus	Thymus
46	chr21:40032000-40033600	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr21:40032000-40033800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
48	chr21:40032000-40033800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
49	chr21:40032000-40033800	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum
50	chr21:40032000-40034000	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links